Dr Lise Alter

Director of Medical, Economic and Public Health Assessment, Haute Autorité de Santé (HAS), France

Dr Lise Alter is the Director of Medical, Economic and Public Health Assessment at the Haute Autorité de Santé (HAS, French HTA body). She is a Dr Public Health and holds a Master's degree in Economics and Management of Health Services. Dr Alter has worked in several French public health administrations including the Social Security Department of the French Ministry of Health and the General Directorate of Health of the French Ministry of Health, where she was medical advisor on Blood, transplant, tissues and cells. From 2012 to 2013 she worked as a medical adviser at the CNAM (the French National Health Insurance body). After 4 years spent in the pharmaceutical industry focusing on oncology she joined the General Directorate of Healthcare Provision of the French Ministry of Health (2018-2019) where she was responsible for health products, innovation, clinical research and telemedicine and telesurveillance. 

Meindert Boysen

David A. Chandler

Chief Executive, Psoriasis and Psoriatic Arthritis Alliance, UK

Dr Anna Gagliardi

Senior Scientist / Professor, University Health Network / University of Toronto, Canada

Anna Gagliardi is a Senior Scientist at the Toronto General Hospital Research Institute and Professor at the University of Toronto. As Principal Investigator, she has published over 120 peer-reviewed articles and secured over $4.7 million in research funding. Her research focuses on guideline implementation, person-centred care for women across the lifespan, and policies to optimize medical device safety, and largely employs evidence syntheses, qualitative methods, and consensus techniques. Anna is currently Chair of the Guidelines International Network’s Implementation Working Group, and a member of committees that promote equity and diversity in research, and DORA principles in performance review of researchers. 

Dr Mireille Goetghebeur

Principal Scientist / Associate Professor, Institut National d'excellence en santé et en services sociaux (INESSS) / University of Montreal, Canada

Mireille Goetghebeur holds a PhD in fundamental sciences and an engineering degree from the University of Montpellier in France. She is Associate Professor at the School of Public Health of the University of Montréal and an associate member of the Research Center of the Ste-Justine University Hospital in Montreal, Canada. She is a pioneer in the development of multidimensional approaches in support of reflection and deliberation for fair and reasonable decisions. Dr Goetghebeur has a solid expertise in the implementation of effective processes rooted in procedural and substantive ethics throughout decision continuums. Over the last 25 years, she has dedicated collaborative efforts at the local and international levels to foster a holistic vision of relevant, equitable and sustainable health and social services systems Since 2017, she is principal scientist at the health and social services technology assessment (HSTA) agency of Quebec, Canada, advancing deliberative processes and collaborative intelligence.

Adrian Griffin

Adrian is actively engaged in numerous multi-stakeholder forums where key issues of HTA and access policy are debated and shaped, such as the HTAi Policy Forum, and initiatives that have brought regulators and HTA agencies together with companies, thus improving transparency and appreciation of different stakeholder perspectives.  

Adrian served on the NICE Technology Appraisal Committee between 2003 and 2020 and was on the Board of Directors for ISPOR (the International Society for Pharmacoeconomics and Outcomes Research), between 2013-15.

Professor Martin Landray MB ChB PhD FRCP

Professor Carole Longson MBE

Professor Tracy Merlin

Director, Adelaide Health Technology Assessment (AHTA); Head, School of Public Health, University of Adelaide, Australia

Professor Tracy Merlin, BA(Hons), MPH, PhD, is the current Chair of the International Network of Agencies for Health Technology Assessment (INAHTA). She is Director and co-founder of Adelaide Health Technology Assessment (AHTA), a large and respected HTA agency established in 2001, and also leads the School of Public Health at the University of Adelaide. Tracy was the first Professor of Health Technology Assessment in Australia. She has been evaluating health technologies of all descriptions for governments for over 20 years. She is a methodologist and a clinical epidemiologist and, among many methodological projects, was responsible for developing the guidance for evaluating and submitting evidence to the Australian Pharmaceutical Benefits Advisory Committee (PBAC), as well as to the Medical Services Advisory Committee (MSAC), for public funding decisions. As part of her PhD in Medicine, she developed a framework for evaluating companion diagnostics and targeted therapies, which was subsequently implemented nationally.

Eva Maria Ruiz de Castilla

Executive Director, Latin America Patients Academy (LAPA), United States

Dr Richard Torbett

Chief Executive, The Association of the British Pharmaceutical Industry, UK

Dr Richard Torbett joined the ABPI in July 2015 and previously held the role of Executive Director of Economic, Health and Commercial Policy before being promoted to Chief Executive in January 2020. Richard has spent the last 15 years working in the pharmaceutical industry. Immediately prior to joining ABPI he was the Chief Economist at the European Federation of Pharmaceutical Industries and Associations (EFPIA) where he was responsible for strategy as well as economic analysis and EFPIA's relations with international economic institutions. He also spent six years at Pfizer Inc., most recently as Senior Director and Head of International Affairs. Richard has degrees in economics from the University of Sussex and the University of Grenoble. He completed his PhD at the Science Policy Research Unit (SPRU), University of Sussex in 2001.

Sjaak Wijma

President and CEO, National Health Care Institute, Netherlands

Sjaak Wijma (1958) studied medicine and specialized in Obstetrics and Gynaecology. He practised ObGy from 1993 to 2016 *in the Martini Hospital in Groningen. During that period he was involved in hospital management and trainee programs for ObGy, both locally and nationally.* Working as a gynaecologist, and especially as president of the board of the Netherlands College of Obstetrics and Gynaecology he was always aiming for better quality of patient centred care in an effective and efficient way. Sjaak Wijma has been a member of the Executive Board of the National Health Care Institute since 2016, where he was appointed chairman on 1 November 2018. His motivation to work with the professional group to improve the effectiveness and quality of patient care is the leitmotiv in his career. He is a member of the advisory board of Stichting Gezond Geboren (healthy pregnancy and *good birth programme) and Stichting Leading the Change (evaluation of care programme)

Professor Hywel Williams

Scientific and Coordinating Centre Programmes Contracts Advisor, NIHR, UK

After training in dermatology in London, Hywel joined the University of Nottingham in 1994 where he now co-directs the Centre of Evidence-Based Dermatology and serves as a consultant paediatric dermatologist at Nottingham University Hospitals NHS Trust. Hywel has been involved in NIHR research funding for 15 years and became Director of the NIHR Health Technology Assessment Programme in 2016. Since stepping down from the HTA in October 2020, Hywel continues to act as a senior advisor to the DHSC participating in ongoing COVID-19 research oversight. Hywel cares passionately about research that is directly relevant to the NHS and is a champion of patient and public involvement in research. His research interests include randomised clinical trials and systematic reviews of interventions to prevent and treat skin diseases, and is one of the most cited clinical dermatologists in the world. Hywel is a proud holder of the British Association of Dermatologists Sir Archibald Gray medal, fellow of the RCP, an NIHR senior investigator and fellow of the Academy of Medical Sciences. He was awarded an OBE in 2021 for his services to higher education and medical research.